E11.31

Type 2 diabetes mellitus with unspecified diabetic retinopathy

Type 2 diabetes mellitus with unspecified diabetic retinopathy is a clinical classification used when a patient with type 2 diabetes presents with retinal microvascular damage that has not been staged as either nonproliferative (NPDR) or proliferative (PDR). Diabetic retinopathy is a leading cause of vision loss globally, resulting from chronic hyperglycemia that damages the small blood vessels of the retina. This damage can lead to vascular leakage (edema), ischemia, and in advanced stages, the growth of abnormal new blood vessels (neovascularization). The unspecified code is often utilized during initial screenings or when clinical documentation does not yet specify the severity level of the retinopathy. Effective management requires stringent glycemic control, blood pressure regulation, and regular ophthalmological surveillance to prevent progression to more severe stages or permanent blindness.

Clinical Symptoms

Blurred or distorted vision
Floaters (spots or dark strings floating in the field of vision)
Fluctuating visual acuity
Dark or empty areas in vision (scotomas)
Impaired night vision
Difficulty with color perception
Metamorphopsia (straight lines appearing wavy)
Sudden vision loss (often associated with vitreous hemorrhage)

Common Causes

Chronic hyperglycemia (long-term elevated blood glucose)
Insulin resistance
Prolonged duration of type 2 diabetes mellitus
Systemic hypertension (high blood pressure)
Hyperlipidemia (elevated blood fats)
Oxidative stress and microvascular inflammation
Genetic predisposition to microvascular complications
Tobacco use

Documentation & Coding Tips

Specify the severity and type of retinopathy to move beyond the unspecified code.

Example: Patient with Type 2 diabetes mellitus presents for follow-up of vision changes. Fundus examination reveals bilateral microaneurysms and intraretinal hemorrhages without neovascularization, consistent with moderate nonproliferative diabetic retinopathy. No evidence of macular edema. Assessment: Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy, bilateral, without macular edema. Plan: Optimize glycemic control, currently A1c 8.2 percent. Follow up with ophthalmology in 6 months.

Billing Focus: Documentation of moderate nonproliferative severity and bilateral laterality supports transition from E11.31 to E11.3313.

Always document the presence or absence of macular edema in conjunction with retinopathy.

Example: Patient with established Type 2 DM and retinopathy. Dilated eye exam performed today shows proliferative diabetic retinopathy in the right eye with evidence of clinincally significant macular edema. Left eye shows stable mild nonproliferative retinopathy without edema. Documentation includes laterality for each eye and the specific manifestation of edema. Risk adjustment includes HCC 18.

Billing Focus: Specific codes exist for retinopathy with macular edema (e.g., E11.3511) which require documentation of both the retinopathy stage and the edema status.

Document the causal relationship between diabetes and eye complications using linking language.

Example: Type 2 diabetes mellitus with ophthalmic manifestations. Patient has developed unspecified retinopathy due to long-standing hyperglycemia. Patient also uses long-term insulin therapy for glycemic management. Current A1c is 9.1 percent. Management includes referral to retina specialist for intravitreal injection evaluation.

Billing Focus: Using terms like with, due to, or secondary to establishes the necessary link for combined coding according to ICD-10-CM guidelines.

Explicitly state the laterality for every ophthalmic diagnosis.

Example: 65-year-old male with Type 2 diabetes mellitus. Evaluation of the retina shows unspecified diabetic retinopathy localized to the left eye only; the right eye remains clear of diabetic changes. Assessment: Type 2 diabetes mellitus with unspecified diabetic retinopathy, left eye.

Billing Focus: Laterality (Right, Left, Bilateral) is a fundamental requirement for 2026 ICD-10 specificity in retinopathy codes.

Include current glycemic control status and long-term medication use such as insulin or oral hypoglycemics.

Example: Type 2 diabetes mellitus with unspecified diabetic retinopathy. Patient is insulin-requiring (Z79.4) for the past 10 years. Recent A1c of 7.8 percent indicates fair control. Retinopathy is being monitored annually. No current vision loss reported.

Billing Focus: Supporting codes like Z79.4 (Long term current use of insulin) should be reported alongside E11.31 to provide a complete clinical picture.

Relevant CPT Codes

99213 - Office or other outpatient visit for the evaluation and management of an established patient, low level of medical decision making, 20-29 minutes
Used for monitoring stable retinopathy and adjusting oral medications in an established patient where MDM is low.
99214 - Office or other outpatient visit for the evaluation and management of an established patient, moderate level of medical decision making, 30-39 minutes
Used when the clinician must manage the retinopathy along with other uncontrolled complications like hypertension or CKD.
92014 - Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; comprehensive, established patient
Standard of care for detailed staging of diabetic retinopathy.
92250 - Fundus photography with interpretation and report
Provides a baseline and tracks progression of hemorrhages or neovascularization.
92134 - Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina
Critical for detecting subclinical macular edema which changes the ICD-10 coding specificity.
92227 - Remote imaging for detection of retinal disease with analysis and report under physician supervision
Used in primary care settings to identify patients who need referral to ophthalmology.
67210 - Destruction of localized lesion of retina, one or more sessions; photocoagulation
A common procedural intervention for nonproliferative retinopathy complications.
99204 - Office or other outpatient visit for the evaluation and management of a new patient, moderate level of medical decision making, 45-59 minutes
Appropriate for the extensive history and review of systems required for a new diabetic patient with complications.
83036 - Hemoglobin; glycosylated (A1C)
Essential monitoring tool for any patient with diabetic complications like retinopathy.
92012 - Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient
Used for interim checks between comprehensive annual exams.